Intellectus Partners, LLC
Position in NTLA — Intellia Therapeutics, Inc.
CIK 1677253
SAN FRANCISCO, CA
Position in NTLA
as of Mar 31, 2026
· filed Apr 10, 2026
Position Value
$698,369
+$238,756 QoQ
Shares Held
54,475
+6.6% QoQ
Ownership
0.039%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NTLA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Intellectus Partners, LLC holds $9,451,424 across 9 Biotechnology names. NTLA ranks #6 (7.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,715 | $2,097,717 | |
| 2 | ABCL |
AbCellera Biologics Inc.
|
546,083 | $1,905,829 | |
| 3 | CORT |
Corcept Therapeutics Inc
|
31,000 | $1,249,610 | |
| 4 | NUVB |
Nuvation Bio Inc.
|
290,417 | $1,245,888 | |
| 5 | QNCX |
Quince Therapeutics, Inc.
|
53,312 | $1,076,902 | |
| 6 | NTLA |
Intellia Therapeutics, Inc.
This page
|
54,475 | $698,369 | |
| 7 | IOVA |
Iovance Biotherapeutics, Inc.
|
136,446 | $478,925 | |
| 8 | RLAY |
Relay Therapeutics, Inc.
|
42,225 | $420,138 |
All Filings in NTLA
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $698,369 | 54,475 | Shares | Sole | 2026-04-10 | |
| 2025-12-31 | $459,613 | 51,125 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $1,502,058 | 86,975 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $806,445 | 85,975 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $588,885 | 82,825 | Shares | Sole | 2025-04-11 | |
| 2024-12-31 | $868,961 | 74,525 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $1,208,853 | 58,825 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $1,303,075 | 58,225 | Shares | Sole | 2024-07-18 | |
| 2024-03-31 | $1,568,070 | 57,000 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $1,696,768 | 55,650 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $1,604,715 | 50,750 | Shares | Sole | 2023-10-25 | |
| 2023-06-30 | $2,096,092 | 51,400 | Shares | Sole | 2023-07-31 | |
| 2023-03-31 | $1,724,296 | 46,265 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $1,593,251 | 45,665 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $2,348,361 | 41,965 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,237,326 | 43,225 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $3,230,181 | 44,450 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $5,619,356 | 47,525 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $6,834,942 | 50,950 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $7,876,921 | 48,650 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $5,748,263 | 71,625 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $3,586,320 | 65,925 | Shares | Sole | 2021-02-18 | |
| 2020-09-30 | $907,522 | 45,650 | Shares | Sole | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||